Xtant Medical Q4 GAAP EPS $(0.03) Misses $(0.02) Estimate, Sales $28.11M Beat $26.55M Estimate
Xtant Medical Q4 GAAP EPS $(0.03) Misses $(0.02) Estimate, Sales $28.11M Beat $26.55M Estimate
Xtant Medical第四季度GAAP每股收益（0.03美元）未達到預期（0.02美元），銷售額爲2811萬美元，超過2655萬美元的預期
Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 percent. This is a 50 percent decrease over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $28.11 million which beat the analyst consensus estimate of $26.55 million by 5.87 percent. This is a 84.07 percent increase over sales of $15.27 million the same period last year.
Xtant Medical Hldgs（美國證券交易所股票代碼：XTNT）公佈的季度虧損爲每股0.03美元（0.03美元），比分析師普遍預期的0.02美元（0.02美元）低50％。這比去年同期每股虧損0.02美元（0.02）下降了50％。該公司公佈的季度銷售額爲2811萬美元，比分析師普遍預期的2655萬美元高出5.87％。這比去年同期的1,527萬美元銷售額增長了84.07％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。